Diabete type 2

Hypoglycemia with Tirzepatide: When and Why to Be Concerned

by

Hypoglycemia with tirzepatide is rare due to its glucose-dependent action. However, certain situations increase the risk. One of the major advantages of tirzepatide compared to older antidiabetic treatments is its low risk of hypoglycemia. This safety is linked to its glucose-dependent mechanism of action. However, certain clinical situations warrant particular vigilance. Why is the risk … Read more

SURMOUNT-2: Tirzepatide in Diabetic and Obese Patients

by

The SURMOUNT-2 study demonstrates that tirzepatide is equally effective in patients combining type 2 diabetes and obesity, with major glycemic benefits. Following the spectacular results of SURMOUNT-1 in non-diabetic patients, the question arose: would tirzepatide be as effective in patients simultaneously presenting with type 2 diabetes … Read more